Triple

T22457237
Position Surface form Disambiguated ID Type / Status
Subject Japan Pharmaceutical Manufacturers Association E555146 entity
Predicate memberOf P10 FINISHED
Object International Federation of Pharmaceutical Manufacturers & Associations
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is a global industry body representing research-based biopharmaceutical companies and national associations, advocating for policies that support innovation and access to medicines worldwide.
E1538013 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: International Federation of Pharmaceutical Manufacturers & Associations | Statement: [Japan Pharmaceutical Manufacturers Association, memberOf, International Federation of Pharmaceutical Manufacturers & Associations]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: International Federation of Pharmaceutical Manufacturers & Associations
Context triple: [Japan Pharmaceutical Manufacturers Association, memberOf, International Federation of Pharmaceutical Manufacturers & Associations]
  • A. European Federation of Pharmaceutical Industries and Associations
    The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association representing the research-based pharmaceutical industry in Europe, advocating for policies that support innovation, patient access to medicines, and a competitive life sciences sector.
  • B. International Pharmaceutical Federation
    The International Pharmaceutical Federation is a global federation representing pharmacists and pharmaceutical scientists, working to advance pharmacy practice, science, and education worldwide.
  • C. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • D. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • E. United States Pharmacopeia
    The United States Pharmacopeia is an official compendium that sets quality, purity, strength, and identity standards for medicines, food ingredients, and dietary supplements used in the United States and many other countries.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: International Federation of Pharmaceutical Manufacturers & Associations
Triple: [Japan Pharmaceutical Manufacturers Association, memberOf, International Federation of Pharmaceutical Manufacturers & Associations]
Generated description
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is a global industry body representing research-based biopharmaceutical companies and national associations, advocating for policies that support innovation and access to medicines worldwide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: International Federation of Pharmaceutical Manufacturers & Associations
Target entity description: The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is a global industry body representing research-based biopharmaceutical companies and national associations, advocating for policies that support innovation and access to medicines worldwide.
  • A. European Federation of Pharmaceutical Industries and Associations
    The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association representing the research-based pharmaceutical industry in Europe, advocating for policies that support innovation, patient access to medicines, and a competitive life sciences sector.
  • B. International Pharmaceutical Federation
    The International Pharmaceutical Federation is a global federation representing pharmacists and pharmaceutical scientists, working to advance pharmacy practice, science, and education worldwide.
  • C. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • D. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • E. United States Pharmacopeia
    The United States Pharmacopeia is an official compendium that sets quality, purity, strength, and identity standards for medicines, food ingredients, and dietary supplements used in the United States and many other countries.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e51fdec8190adfdf9f8a6362221 completed April 16, 2026, 5:37 p.m.
NER Named-entity recognition batch_69f15b7c428c8190847a259eef969525 completed April 29, 2026, 1:14 a.m.
NED1 Entity disambiguation (via context triple) batch_6a0b0c7fc40081909f27eb081ac156f1 completed May 18, 2026, 12:56 p.m.
NEDg Description generation batch_6a0b0ddb116c8190b19f9a01abb737e6 completed May 18, 2026, 1:02 p.m.
NED2 Entity disambiguation (via description) batch_6a0b0e4402e481909210c5feff3fcddf completed May 18, 2026, 1:04 p.m.
Created at: April 16, 2026, 8:48 p.m.